Increased Corrected Index of Cardiac Electrophysiological Balance in Behçet's Disease: Association with Disease

Aylin Dolu Karaca1, Mehmet Cansel2, Yücel Karaca3

  • 1Department of Rheumatology, Adıyaman Training and Research Hospital, 02200 Adıyaman, Türkiye.

Insights

Patients with Behçet's disease (BD) show altered cardiac electrophysiological balance, indicated by higher index of cardiac electrophysiological balance (iCEB) and corrected index (iCEBc) values. Longer disease duration is linked to these electrophysiological changes, suggesting iCEBc as a marker for arrhythmia risk.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Rheumatology

Background:

  • Behçet's disease (BD) is a chronic inflammatory condition increasing ventricular arrhythmia and sudden cardiac death risk.
  • The index of cardiac electrophysiological balance (iCEB) and its corrected form (iCEBc) are novel ECG markers for arrhythmic risk.
  • This study evaluates iCEB and iCEBc in BD patients, assessing links to disease duration and inflammation.

Purpose of the Study:

  • To assess cardiac electrophysiological balance using iCEB and iCEBc in Behçet's disease patients.
  • To investigate the association between iCEB/iCEBc and disease duration or inflammatory activity (CRP).
  • To identify predictors of iCEBc in BD patients.

Main Methods:

  • Observational, cross-sectional study of 81 BD patients and 84 controls.
  • Standard 12-lead ECG to calculate QT, QTc, QRS, iCEB (QT/QRS), and iCEBc (QTc/QRS).
  • Correlation and multivariable regression analyses to explore relationships with disease duration and CRP.

Main Results:

  • BD patients had significantly higher QTc, iCEB, and iCEBc compared to controls.
  • Elevated C-reactive protein (CRP) levels were observed in BD patients.
  • Disease duration strongly correlated with QTc, iCEB, iCEBc, and CRP; it was the sole independent predictor of iCEBc.

Conclusions:

  • Behçet's disease patients exhibit impaired cardiac electrophysiological balance (higher iCEB and iCEBc).
  • Disease duration is a significant factor associated with electrophysiological alterations in BD.
  • iCEBc shows potential as a noninvasive ECG marker for ventricular arrhythmia risk in BD.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...